Komal Sharma

Komal Sharma

Auto-generated profile, based on publicly available information

Komal Sharma

Department of Pharmacology, Bhupal Nobles’ University, Udaipur, Rajasthan- 313001, India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2024 in Biosciences Biotechnology Research Asia
Verified
Journal Article
Open access
MYManish Kumar Yadav
Manish Kumar Yadav
KSKomal Sharma
Komal Sharma
ASAJAY KUMAR SHUKLA
AJAY KUMAR SHUKLA
Aim and objective: The study aimed to use in-vitro DPPH and the HaCaT skin cancer cell line method to examine hydroalcoholic leaf extract's antioxidant and anticancer properties from Nerium oleander. Methodology: The hydroalcoholic extract of Nerium oleander was prepared to assess antioxidants and anti-cancers using the in-vitro DPPH and MTT assay method against the HaCaT skin cancer cell line. Results: The antioxidant activity of Nerium oleander hydroalcoholic leaves extract was found to be IC50 =896.9µg/ml, equivalent to IC50= 10.93µg/ml of ascorbic acid, and IC50 = 91.49±0.181µg/ml effective against the HaCaT skin cancer cell line. Further research against carcinogenesis from the hydroalcoholic extract of Nerium oleander leaves, which demonstrated therapeutic potential against cancer cells, can yield significant results. Conclusion: The bioactive chemicals of Nerium oleander leaves may be beneficial for treating skin cancer. Limitations: The study's emphasis on in-vitro tests, which might not accurately capture the nuances of in-vivo settings, has limitations. To confirm the extract's potential for medicinal use, more research should examine its safety and efficacy in animal models and human trials.

1 February 2025 in Journal of Disease and Global Health
Verified
Journal Article
Open access
PDF file
Ranjan Kumar SinghRanjan Kumar Singh
Ranjan Kumar Singh
KSKomal Sharma
Komal Sharma
Diabetes prevalence has increased dramatically in almost every part of the world in recent decades. The increased number of persons with diabetes or those who have had diabetes for a longer period is anticipated to change the disease profile in many communities throughout the world, owing to a higher frequency of diabetes-specific comorbidities such as kidney failure and peripheral artery disease. The epidemiology of other illnesses commonly linked with diabetes, such as infections and cardiovascular disease, may also shift, with significant consequences for the quality of life, healthcare needs, and economic expenditures. Diabetes (DM) is becoming more common at an alarming pace throughout the world. According to the International Diabetes Federation, an estimated 415 million individuals worldwide suffered from this illness in 2015. Diabetes complications include increased morbidity, disability, and death, posing a danger to the economies of all countries, particularly emerging ones. The current understanding of the global burden and variance in diabetes-related complications is inadequate. According to the available statistics, rates of myocardial infarction, stroke, and amputation are falling among diabetics, coinciding with lower mortality. However, the majority of these statistics originate from research conducted in only a few high-income nations. Other diabetic consequences, such as end-stage renal disease, retinopathy, and cancer, have received less attention. Obesity, insulin resistance, hyperglycemia, and hyperlipidemia are all variables that influence the development and progression of diabetes problems. In this review, we have included all the major complications and their pathophysiology along with their possible mechanism of action and the possible treatment with herbal or medicinal plants. This review will explore new ways of the diabetic complications around the globe.

15 September 2024 in International Journal of Pharmaceutical Chemistry and Analysis
Verified
Journal Article
Open access
PDF file
Ashwin Singh ChouhanAshwin Singh Chouhan
Ashwin Singh Chouhan
KSKomal Sharma
Komal Sharma
ABAnil Bhandari
Anil Bhandari
The number of corona infections in India is rising quickly, yet those who have had dengue have been found to have developed internal immunity that helps them fight against corona. A community diagnosis survey was carried out in Jodhpur, Rajasthan, India, in an urban practice area. A survey was conducted to find out the health state and sociodemographic characteristics of one hundred dengue patients. Data regarding their present state of health was collected. The right tools were used to analyse the data. Using Student's Z-test and T-test statistical analysis, the relationship between COVID-19 and dengue was examined. At P < 0.50, statistical significance was established. In the general survey, corona infection did not follow dengue. Among the 27 dengue patients under study, the median age of the population was 69% under the age of 19–27, 20% over the age of 28–40, and 3% of the patients were female and between the ages of 41 and 55. 43 (43%), compared to 56 (56%) were less likely. A set of questions was posed to 100 dengue patients, with a statistical significance limit of p < 0.50. It was determined from this study that none of the patients who had previously had dengue had corona infection. According to our research, the majority of men and women aged 19 to 27 who have dengue are not at risk of developing corona. We can also conclude that during dengue recovery, the body produces certain antibodies which help in the fight against corona and stop the virus from spreading.